Medpace Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Medpace Holdings

10/02/2025 22:01

* Medpace Holdings Inc  MEDP.OQ  reported quarterly adjusted
earnings of $3.67​​ per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $2.46.  The mean expectation of eight analysts
for the quarter was for earnings of $2.96 per share. Wall Street
expected results to range from $2.80  to $3.09 per share.
    * Revenue rose 7.7% to $536.59 million from a year ago;
analysts
expected $534.78 million. 
    * Medpace Holdings Inc's reported EPS for the quarter was
$3.67​.
    * The company reported quarterly net income of $117.02
million.
    * Medpace Holdings Inc shares had risen by 6.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Medpace Holdings
Inc is $350.00 
This summary was machine generated from LSEG data February 10 at
10:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      2.96           3.67           Beat
 Sep. 30 2024      2.78           3.01           Beat
 Jun. 30 2024      2.54           2.75           Beat
 Mar. 31 2024      2.47           3.20           Beat